An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer.
Lim SM, Chung WY, Nam KH, Kang SW, Lim JY, Kim HG, Shin SH, Sun JM, Kim SG, Kim JH, Kang CW, Kim HR, Cho BC.
Lim SM, et al. Among authors: shin sh.
Eur J Cancer. 2015 Aug;51(12):1588-95. doi: 10.1016/j.ejca.2015.05.020. Epub 2015 Jun 9.
Eur J Cancer. 2015.
PMID: 26070683
Clinical Trial.